Research Historical Cash Flow

REFR Stock  USD 1.38  0.01  0.73%   
Analysis of Research Frontiers cash flow over time is an excellent tool to project Research Frontiers future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 104.9 K or Total Cash From Financing Activities of 414.2 K as it is a great indicator of Research Frontiers ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Research Frontiers latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Research Frontiers is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Research Frontiers Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

About Research Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Research balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Research's non-liquid assets can be easily converted into cash.

Research Frontiers Cash Flow Chart

At this time, Research Frontiers' End Period Cash Flow is relatively stable compared to the past year. As of 02/27/2025, Sale Purchase Of Stock is likely to grow to about 343.2 K, while Free Cash Flow is likely to drop (2.2 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.
Most accounts from Research Frontiers' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Research Frontiers current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Research Frontiers Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
At this time, Research Frontiers' End Period Cash Flow is relatively stable compared to the past year. As of 02/27/2025, Sale Purchase Of Stock is likely to grow to about 343.2 K, while Free Cash Flow is likely to drop (2.2 M).

Research Frontiers cash flow statement Correlations

0.170.340.140.030.60.10.17-0.60.430.110.090.050.110.54-0.510.090.070.070.120.47
0.170.01-0.570.83-0.510.040.19-0.73-0.110.260.44-0.45-0.220.270.12-0.390.650.07-0.16-0.23
0.340.010.22-0.170.34-0.260.08-0.060.240.1-0.320.410.150.19-0.10.5-0.110.020.060.14
0.14-0.570.22-0.440.510.07-0.270.360.410.38-0.340.290.44-0.060.040.27-0.520.180.160.22
0.030.83-0.17-0.44-0.56-0.250.19-0.63-0.310.280.14-0.77-0.220.340.06-0.720.44-0.23-0.34-0.55
0.6-0.510.340.51-0.560.0-0.20.270.45-0.25-0.360.560.150.34-0.520.54-0.350.050.010.32
0.10.04-0.260.07-0.250.0-0.02-0.090.23-0.150.750.060.29-0.180.12-0.080.540.690.360.39
0.170.190.08-0.270.19-0.2-0.02-0.380.19-0.170.11-0.450.480.120.14-0.260.38-0.28-0.10.15
-0.6-0.73-0.060.36-0.630.27-0.09-0.38-0.06-0.37-0.440.530.01-0.350.080.44-0.460.010.0-0.2
0.43-0.110.240.41-0.310.450.230.19-0.060.2-0.10.20.220.23-0.080.38-0.090.130.140.5
0.110.260.10.380.28-0.25-0.15-0.17-0.370.20.03-0.110.02-0.150.32-0.01-0.290.090.080.18
0.090.44-0.32-0.340.14-0.360.750.11-0.44-0.10.03-0.180.14-0.380.09-0.240.610.580.340.38
0.05-0.450.410.29-0.770.560.06-0.450.530.2-0.11-0.18-0.02-0.180.00.93-0.390.240.220.35
0.11-0.220.150.44-0.220.150.290.480.010.220.020.14-0.02-0.090.440.020.11-0.09-0.030.19
0.540.270.19-0.060.340.34-0.180.12-0.350.23-0.15-0.38-0.18-0.09-0.22-0.170.25-0.39-0.38-0.31
-0.510.12-0.10.040.06-0.520.120.140.08-0.080.320.090.00.44-0.220.010.11-0.15-0.2-0.18
0.09-0.390.50.27-0.720.54-0.08-0.260.440.38-0.01-0.240.930.02-0.170.01-0.430.130.110.45
0.070.65-0.11-0.520.44-0.350.540.38-0.46-0.09-0.290.61-0.390.110.250.11-0.430.29-0.1-0.16
0.070.070.020.18-0.230.050.69-0.280.010.130.090.580.24-0.09-0.39-0.150.130.290.450.45
0.12-0.160.060.16-0.340.010.36-0.10.00.140.080.340.22-0.03-0.38-0.20.11-0.10.450.51
0.47-0.230.140.22-0.550.320.390.15-0.20.50.180.380.350.19-0.31-0.180.45-0.160.450.51
Click cells to compare fundamentals

Research Frontiers Account Relationship Matchups

Research Frontiers cash flow statement Accounts

202020212022202320242025 (projected)
Change In Cash(1.8M)(4.5M)4.0M(1.8M)(1.6M)(1.5M)
Free Cash Flow(2.3M)(1.8M)(2.2M)(2.3M)(2.1M)(2.2M)
Other Non Cash Items(120.7K)73.0K201.9K37.9K34.1K32.4K
Capital Expenditures56.5K1.1K1.3K1.6K1.8K1.7K
Total Cash From Operating Activities(2.3M)(1.8M)(2.2M)(2.3M)(2.1M)(2.2M)
Net Income(2.3M)(1.8M)(2.7M)(1.9M)(1.7M)(1.8M)
End Period Cash Flow4.8M270.0K4.2M2.5M2.8M4.2M
Change In Working Capital(185.8K)(258.1K)(122.8K)(741.4K)(667.3K)(633.9K)
Other Cashflows From Financing Activities(52.8K)86.3K2.7M484.5K557.2K366.7K
Depreciation67.1K10.1K175.2K172.1K198.0K104.9K
Total Cash From Financing Activities486.3K86.3K3.5M484.5K436.1K414.2K
Begin Period Cash Flow6.6M4.8M270.0K4.2M4.9M4.0M
Change To Liabilities1.9K(156.8K)56.2K(10.4K)(9.3K)(8.9K)
Total Cashflows From Investing Activities(65.3K)(52.8K)(2.8M)2.7M2.4M2.5M
Change To Account Receivables(23.6K)(277.8K)100.3K(508.8K)(457.9K)(435.0K)
Stock Based Compensation327.6K217.0K232.3K144.7K130.3K123.7K
Investments(52.8K)(2.8M)2.7M55.6K63.9K67.1K
Cash And Cash Equivalents Changes1.2M3.6M(1.8M)4.0M4.6M4.8M
Change To Netincome1.7M408.9K290.0K434.2K390.8K700.0K
Change To Operating Activities(6.1K)2.3K(36.4K)(212.6K)(191.4K)(181.8K)

Pair Trading with Research Frontiers

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Research Frontiers position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Research Frontiers will appreciate offsetting losses from the drop in the long position's value.

Moving together with Research Stock

  0.74KE Kimball ElectronicsPairCorr
  0.85EBON Ebang InternationalPairCorr

Moving against Research Stock

  0.88NOK Nokia Corp ADRPairCorr
  0.85JBL Jabil CircuitPairCorr
  0.78FKWL Franklin Wireless CorpPairCorr
  0.77CLS CelesticaPairCorr
  0.58CDW CDW CorpPairCorr
The ability to find closely correlated positions to Research Frontiers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Research Frontiers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Research Frontiers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Research Frontiers Incorporated to buy it.
The correlation of Research Frontiers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Research Frontiers moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Research Frontiers moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Research Frontiers can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Research Stock Analysis

When running Research Frontiers' price analysis, check to measure Research Frontiers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Research Frontiers is operating at the current time. Most of Research Frontiers' value examination focuses on studying past and present price action to predict the probability of Research Frontiers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Research Frontiers' price. Additionally, you may evaluate how the addition of Research Frontiers to your portfolios can decrease your overall portfolio volatility.